ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Disparities"

  • Abstract Number: 1083 • ACR Convergence 2025

    How Do Social Determinants of Health Differ Across Age and Disability Groups Among Adult Medicare Advantage Enrollees with Systemic Lupus Erythematosus?

    Alexjandro Daviano1, Vijay R. Nadipelli2, Yihua Xu1, Karen Worley2, Shireen Haq1, Josephine Ohioma3, Jeffrey J. Ellis2, Brandon T. Suehs1 and S. Sam Lim4, 1Humana Healthcare Research, Inc., Louisville, KY, 2GSK, Global Real-World Evidence & Health Outcomes Research, Collegeville, PA, 3GSK, US Medical Affairs, Philadelphia, PA, 4Emory University School of Medicine, Atlanta, GA

    Background/Purpose: Management of patients with SLE should consider social determinants of health (SDoH) and their impact on access, treatment, and patient outcomes; however, such a…
  • Abstract Number: 1013 • ACR Convergence 2025

    All roads lead to Rheum? Modeling scenarios of new patients-to-pediatric rheumatologist ratios in different US states

    Gabriela Accetta Rojas1, Evan Mulvihill2, Salma Siddique1 and Annemarie Brescia1, 1Nemours Children's Hospital of Delaware, Wilmington, DE, 2Nemours/A.I.duPont Hospital for Children, Wilmington, DE

    Background/Purpose: Rheumatology is among the pediatric subspecialties with the lowest workforce density in the US1. Initial management of most of the pediatric rheumatologic conditions relies…
  • Abstract Number: 1882 • ACR Convergence 2025

    Vessels Under Fire: National Mortality Trends in Systemic Vasculitides in the United States, 1999–2020

    Aziz-ur-Rahman Khalid1, Ghassan Makhoul2, Hasan Munshi2, Islam Rajab2, Emmanuel Olumuyide3, MD Walid Akram Hussain2, Ahmed Huzien2 and Robert Lahita4, 1St. Joseph's University Medical Center, wayne, 2St. Josephs University Medical Center, Paterson, 3Advocate Illinois Masonic Medical Center, Chicago, 4St. Josephs University Medical Center, Wayne, NJ

    Background/Purpose: Systemic vasculitides are rare but potentially life-threatening inflammatory disorders affecting blood vessels. Despite therapeutic advances, national mortality trends across vasculitis subtypes remain poorly defined.…
  • Abstract Number: 1082 • ACR Convergence 2025

    Lupus Patient Navigator Program for Improving Care Adherence for Minority Patients

    Rashi Vora1, Samiha Karim2, Dulaney Wilson3, Jasvinder Singh4, Gary Gilkeson1, Jim Oates1 and Diane Kamen5, 1Medical University of South Carolina, Charleston, SC, 2Emory University, Atlanta, GA, 3Medical University of South Carolina, Charleston, 4Baylor College of Medicine, Houston, TX, 5Medical University of South Carolina, Johns Island, SC

    Background/Purpose: Minority patients with systemic lupus erythematosus (SLE) experience a higher disease burden and encounter more barriers to care than White patients, resulting in worse…
  • Abstract Number: 1012 • ACR Convergence 2025

    Racial and Gender Disparities in Gout Clinical Trials

    Fizza Zulfiqar1, Dania Kaur2, Meaghan Bethea3, Taylor Spencer4, Samhitha Bitla5, Abhinav Vyas6 and Camelia Arsene7, 1Trinity Health Oakland/Wayne State University, Pontiac, MI, 2North Alabama Medical Center, Muscle Shoals, AL, 3Trinity Health Oakland Hopsital, Pontiac, MI, 4Trinity Health Oaklnd Hospital, Pontiac, MI, 5Trinity Health Oakland Hospital, Pontiac, MI, 6Vanderbilt University, Nashvile, TN, 7Trinity Health Oakland Hospital, Pontiac

    Background/Purpose: To develop effective novel treatment strategies for Gout disease that cater to patients from diverse backgrounds, it is crucial that all racial groups, without…
  • Abstract Number: 1881 • ACR Convergence 2025

    Silent Impact: Two Decades of Sjögren’s Syndrome Mortality in the United States

    Aziz-ur-Rahman Khalid1, Ghassan Makhoul2, Hasan Munshi2, Islam Rajab2, MD Walid Akram Hussain2, Reshma John2, Elvira Assaf2, Amer Al Badawy2, Barbare Khatiashvili2, Rouba Isshak2, John Salama2, Ibrahim Sabah2 and Robert Lahita3, 1St. Joseph's University Medical Center, wayne, 2St. Josephs University Medical Center, Paterson, 3St. Josephs University Medical Center, Wayne, NJ

    Background/Purpose: Sjögren’s syndrome is a chronic autoimmune disease characterized by lymphocytic infiltration of exocrine glands with potential systemic involvement. Despite its known complications, population-level mortality…
  • Abstract Number: 1081 • ACR Convergence 2025

    Insurance, Gender, and COVID-19’s Effects on Health Inequity in Rheumatoid Arthritis: A 12-Year Long Population Assessment

    Ramsha Riaz1, Lifang Zhang2, Andrea Berger2, Hema Srinivasan2, Lisa Schroeder3 and Jonida Cote4, 1Geisinger Medical Center, Danville, PA, 2Geisinger Health System, Danville, PA, 3Geisinger, Danville, PA, 4Geisinger Health System, Wilkes-Barre, PA

    Background/Purpose: Recognizing health care disparities in Rheumatoid Arthritis is crucial to improving outcomes. This study analyzes factors contributing to RA care inequities.Methods: We examined RA…
  • Abstract Number: 0720 • ACR Convergence 2025

    Current State of Racial, Ethnic, Sex, and Geographical Diversity in ANCA-associated vasculitis and Giant Cell Arteritis Trials

    Manuel Carpio Tumba1, Aida Mohamadi2, Diana Louden3, Victor Pimentel-Quiroz4, Michael Putman5, Didem Saygin6, Raisa Lomanto Silva7 and Sebastian E Sattui8, 1University of Pittsburgh, Pittsburgh, PA, 2Tehran University of Medical Sciences, Tehran, Iran, 3University of Washington, Seattle, WA, 4Universidad Científica del Sur, San Isidro, Peru, 5The Medical College of Wisconsin, Milwaukee, WI, 6Rush University Medical Center, Chicago, IL, 7Massachusetts General Hospital, Boston, MA, 8Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, PA

    Background/Purpose: Randomized controlled trials (RCTs) generate unbiased efficacy estimates and are required for regulatory approval. Understanding the degree to which they include racial, ethnic, sex,…
  • Abstract Number: 1880 • ACR Convergence 2025

    Rheumatoid Arthritis Mortality in the U.S. (1999–2020): A Decline in Rates, But Not in Disparities

    Aziz-ur-Rahman Khalid1, Ghassan Makhoul2, Hasan Munshi2, Islam Rajab2, Emmanuel Olumuyide3, MD Walid Akram Hussain2, Aqsa Sorathia2, Elvira Assaf2, Amer Al Badawy2, John Salama2 and Robert Lahita4, 1St. Joseph's University Medical Center, wayne, 2St. Josephs University Medical Center, Paterson, 3Advocate Illinois Masonic Medical Center, Chicago, 4St. Josephs University Medical Center, Wayne, NJ

    Background/Purpose: Rheumatoid arthritis (RA) is a systemic autoimmune disease associated with increased morbidity and mortality. While treatments have evolved, national trends and sociodemographic disparities in…
  • Abstract Number: 1080 • ACR Convergence 2025

    Are Minority Populations Truly Vaccine Hesitant? A Provider-Based Approach to RSV Vaccine Uptake Suggests Otherwise.

    pavana sakhamuri1, Stephen Lindsey2, Cathryn Leggio3 and Ellen Mire4, 1LSUHSC, Dept of Rheumatology, Lafayette, LA, 2LSUHSC, Dept of Rheumatology, NEW ORLEANS, LA, 3University Medical center, NEW ORLEANS, LA, 4LSUHSC, Dept of Medicine, NEW ORLEANS, LA

    Background/Purpose: Respiratory Syncytial Virus (RSV) is a leading cause of hospitalization and mortality in older adults and young children, particularly those with chronic illnesses or…
  • Abstract Number: 0785 • ACR Convergence 2025

    It Takes a Community: Exploring the Importance of Community-Level Social Determinants of Health in Total Knee Arthroplasty Outcomes

    Chloe Heiting1, Yiyuan Wu2, Susan Goodman3, Peter Sculco4, Fei Wang2, Rich Caruana5, Peter Cram6, Said Ibrahim7 and Bella Mehta8, 1Northwell Health, New Hyde Park, NY, 2Weill Cornell Medicine, New York, NY, 3Hospital for Special Surgery, Weill Cornell Medicine, New York, NY, 4Hospital for Special Surgery, New York, NY, 5Microsoft, Redmond, WA, 6University of Maryland School of Medicine, Baltimore, MD, 7Thomas Jefferson University, Philadelphia, PA, 8Hospital for Special Surgery, Weill Cornell Medicine, Jersey City, NJ

    Background/Purpose: Despite changing trends and increased utilization of total knee arthroplasty (TKA) in the United States,1 there are still prominent racial and ethnic disparities in…
  • Abstract Number: 0194 • ACR Convergence 2024

    Machine Learning Methods to Predict Cardiovascular Risk in Hispanic Patients with Systemic Lupus Erythematosus

    Ariana Gonzalez-Melendez1, Jeann Hernandez-Franco2, Dylan Cedres-Rivera3 and Abiel Roche-Lima3, 1University of Puerto Rico - Medical Science Campus, Guaynabo, PR, 2University of Puerto Rico, San Juan, PR, Puerto Rico, 3Center for Collaborative Research in Health Disparities, University of Puerto Rico Medical Sciences Campus, San Juan, Puerto Rico, San Juan, PR, Puerto Rico

    Background/Purpose: The most common cause of death among patients with systemic lupus erythematosus (SLE) is cardiovascular disease (CVD). Previous studies have performed cardiovascular risk stratification;…
  • Abstract Number: 1012 • ACR Convergence 2024

    Disparities in Time to Diagnosis for Radiographic Axial Spondyloarthritis

    Renato Ferrandiz1, Gabriela Rabasa2, Sarah Gasman3, Brooke Mcginley4, Rachael Stovall5, S. Reza Jafarzadeh6, Jean Liew6 and Maureen Dubreuil7, 1North Alabama Medical Center, Florence, AL, 2Department of Developmental Medicine, Boston Children's Hospital, Boston, MA, 3Boston University School of Medicine, Boston, MA, 4Boston University, Boston, MA, 5University of Washington, Seattle, WA, 6Boston University Chobanian & Avedisian School of Medicine, Boston, MA, 7Section of Rheumatology, Boston University School of Medicine, Boston, MA

    Background/Purpose: Radiographic axial spondyloarthritis (r-axSpA; formerly ankylosing spondylitis) has an average diagnostic delay of 7 years, which can lead to a diminished quality of life…
  • Abstract Number: 1246 • ACR Convergence 2024

    Long-Term Outcomes Based on the Sex of the Rheumatologist in a Prospective Cohort of RA Patients Receiving Biological Therapies

    Alessandro Giollo1, Mariangela Salvato2, Margherita Zen3 and doria Andrea4, 1Azienda Ospedale Università Padova, Padova, Padua, Italy, 2University of Padua, Padova, Italy, 3University of Padova, Padova, Padua, Italy, 4University of Padova, Padova, Italy

    Background/Purpose: To explore the influence of the rheumatologist's sex on long-term outcomes in patients with rheumatoid arthritis (RA) undergoing biologic therapy.Methods: This is a prospective,…
  • Abstract Number: 1926 • ACR Convergence 2024

    Race/ethnicity Is Associated with Disease Severity in Pediatric Patients with ANCA-associated Vasculitis Hospitalized in the United States

    Rob Valdovinos1, William Soulsby2 and Emily von Scheven2, 1UCSF Benioff Children's Hospital, San Francisco, CA, 2University of California, San Francisco, San Francisco, CA

    Background/Purpose: Race and ethnicity are societal constructs that contribute to health disparities. Small studies have found that Hispanic patients with ANCA-associated vasculitis (AAV) are more…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 22
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology